当前位置:首页 - 行情中心 - 迈克生物(300463) - 财务分析

迈克生物

(300463)

  

流通市值:51.66亿  总市值:63.55亿
流通股本:4.91亿   总股本:6.05亿

迈克生物(300463)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.07亿元,每股收益0.01元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益631228.85万元,未分配利润378304.05万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产799071.96万元,负债167843.11万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入475,257,129.692,170,468,429.261,607,884,075.221,075,034,096.39
营业总成本471,357,185.172,158,960,092.161,517,055,095.031,006,684,937.26
其他经营收益
营业利润10,073,424.52-60,759,870.8361,984,402.1655,638,080.22
利润总额8,404,477.88-99,537,391.4734,501,768.5628,409,089.61
净利润6,602,934.01-41,494,108.2943,024,083.7736,539,905.57
每股收益
其他综合收益19,257.97-15,250,936.63-15,058,213.16-15,121,818.95
综合收益总额6,622,191.98-56,745,044.9227,965,870.6121,418,086.62
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计3,199,033,996.163,228,033,606.983,412,441,963.833,554,900,187.2
非流动资产:
非流动资产合计4,791,685,562.234,766,541,926.14,576,543,741.214,455,913,445.34
资产总计7,990,719,558.397,994,575,533.087,988,985,705.048,010,813,632.54
流动负债:
流动负债合计1,011,850,410.341,053,376,455.01980,670,442.621,016,981,836.52
非流动负债:
非流动负债合计666,580,651.69635,532,773.69628,930,234.34621,545,187.24
负债合计1,678,431,062.031,688,909,228.71,609,600,676.961,638,527,023.76
所有者权益(或股东权益):
归属于母公司股东权益合计6,284,639,216.316,275,633,895.196,326,115,358.66,322,440,254.33
股东权益合计6,312,288,496.366,305,666,304.386,379,385,028.086,372,286,608.78
负债和股东权益合计7,990,719,558.397,994,575,533.087,988,985,705.048,010,813,632.54
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计637,571,828.442,826,351,272.141,991,748,511.641,355,589,579.14
经营活动现金流出小计489,374,155.872,224,018,770.951,681,369,859.761,193,799,946.12
经营活动产生的现金流量净额148,197,672.57602,332,501.19310,378,651.88161,789,633.02
投资活动产生的现金流量:
投资活动现金流入小计8,053,804.09203,071,388.18152,912,142.2789,807,397.03
投资活动现金流出小计125,270,799.55925,656,453.34637,394,934.85410,607,484.42
投资活动产生的现金流量净额-117,216,995.46-722,585,065.16-484,482,792.58-320,800,087.39
筹资活动产生的现金流量:
筹资活动现金流入小计227,704,235.03817,636,648.58830,309,635.83700,376,722.6
筹资活动现金流出小计200,750,449.59675,245,451.72628,546,211.12530,951,041.35
筹资活动产生的现金流量净额26,953,785.44142,391,196.86201,763,424.71169,425,681.25
汇率变动对现金及现金等价物的影响-4,716,771.61-3,830,668.28-1,717,889.33523,487.41
现金及现金等价物净增加额53,217,690.9418,307,964.6125,941,394.6810,938,714.29
期末现金及现金等价物余额712,629,395.52659,411,704.58667,045,134.65652,042,454.26
补充资料:
现金及现金等价物的净增加额-18,307,964.61-10,938,714.29
最新报告期:2026-04-30
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
华泰证券代雯,高鹏,杨昌源0.160.250.332026-04-30
TOP↑